| POU2AF2/C11orf53 functions as a coactivator of POU2F3 by maintaining chromatin accessibility and enhancer activity AP Szczepanski, N Tsuboyama, J Watanabe, R Hashizume, Z Zhao, ... Science Advances 8 (40), eabq2403, 2022 | 31 | 2022 |
| Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer N Tsuboyama, R Wang, AP Szczepanski, H Chen, Z Zhao, L Shi, L Wang Oncogene 41 (15), 2152-2162, 2022 | 15 | 2022 |
| PAX9 determines epigenetic state transition and cell fate in cancer Z Zhao, AP Szczepanski, N Tsuboyama, H Abdala-Valencia, YA Goo, ... Cancer research 81 (18), 4696-4708, 2021 | 11 | 2021 |
| Modeling robust COVID-19 intensive care unit occupancy thresholds for imposing mitigation to prevent exceeding capacities M Runge, RAK Richardson, PA Clay, A Bell, TM Holden, M Singam, ... PLOS global public health 2 (5), e0000308, 2022 | 10 | 2022 |
| MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer N Tsuboyama, AP Szczepanski, Z Zhao, L Wang Genome biology 23 (1), 206, 2022 | 1 | 2022 |
| A SWI/SNF-dependent transcriptional regulation mediated by POU2AF2/C11orf53 at enhancer A Szczepanski, N Tsuboyama, H Lyu, P Wang, O Beytullahoglu, T Zhang, ... Nature Communications 15 (1), 2067, 2024 | | 2024 |
